Kidney Health in Kids with Inflammatory Bowel Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter cross-sectional study collects clinical and lab data from children aged 2–17 with IBD and matched controls to estimate CKD prevalence. It will describe patient characteristics and explore links between CKD, disease activity, and therapies. The aim is to improve understanding of kidney complications in pediatric IBD and inform early detection efforts. The study uses observational data from pediatric units in Alessandria, Italy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pediatric patients aged between 2 and 17 years
* For the case group: confirmed diagnosis of inflammatory bowel disease according to Porto criteria
* For the control group: absence of current or previous diagnosis of inflammatory bowel disease
* Availability of clinical and laboratory data required for study evaluation
* Written informed consent from parent or legal guardian, and assent from the minor when applicable

Exclusion Criteria:

* History of pre-existing renal disease (congenital or acquired before IBD diagnosis)
* Presence of conditions that may affect renal function (e.g., diabetes mellitus, hypertension, chronic use of nephrotoxic drugs)
* Lack of informed consent

Where it's running

• Pediatric Unit
  Alessandria, Piedmont, Italy Recruiting

Study contacts

• Study coordinator: Clinical Trial Center (CTC) Clinical Trial Center (CTC)
• Email: clinicaltrialcenter@ospedale.al.it
• Phone: 0131206893

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarker Discovery and Validation Platform for Inflammatory Bowel Disease

  Researchers are testing biomarker models to see if they can measure and predict inflammation and treatment response in people with Crohn's disease, ulcerative colitis, or related IBD.

  Recruiting Sixth Affiliated Hospital, Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07686406

• Tissue repair in inflammatory bowel disease using organoid technology

  This project will try organoid techniques on intestinal samples from adults with Crohn's disease or ulcerative colitis to see how their gut lining repairs after inflammation.

  Recruiting Assistance Publique Hopitaux De Marseille · Marseille · NCT06805890

• Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?

  This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.

  Recruiting Mahidol University · Bangkok Noi, Bangkok · NCT07775794

• Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission

  This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07752446

• Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk

  This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.

  Recruiting Jena University Hospital · Jena · NCT07716488

• Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease

  This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.

  Recruiting at 2 sites Maastricht University Medical Center · 's-Hertogenbosch and 2 other locations · NCT07647640

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.